Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma model

BACKGROUND: Antiangiogenic therapies are considered promising for the treatment of glioblastoma (GB). The non-collagenous C-terminal globular NC1 domain of type VIII collagen a1 chain, Vastatin, is an endogenous antiangiogenic polypeptide. Sustained enhanced expression of Vastatin was shown to inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yi, Li, Jun, Woo, Yat Ming, Shen, Zan, Yao, Hong, Cai, Yijun, Lin, Marie Chia-mi, Poon, Wai Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307880/
https://www.ncbi.nlm.nih.gov/pubmed/28193190
http://dx.doi.org/10.1186/s12885-017-3125-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307880/
https://www.ncbi.nlm.nih.gov/pubmed/28193190
http://dx.doi.org/10.1186/s12885-017-3125-8

Ejemplares similares